Prognostic indices and therapy in IgA nephropathy: Toward a solution

被引：6

作者：

Ballardie, F. W. ^{[1
]}

Cowley, R. D. ^{[1
]}

机构：

[1] Univ Manchester, Manchester Royal Infirm, Dept Nephrol & Internal Med, Manchester M13 9WL, Lancs, England

来源：

KIDNEY INTERNATIONAL | 2008年 / 73卷 / 03期

关键词：

D O I：

10.1038/sj.ki.5002660

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

IgA nephropathy is the primary renal disease with the greatest impact on services. The paucity of trials with high evidence-based standards gives emphasis to issues of the rationalization of therapies. Now that certain treatments are increasingly accepted and others under evaluation, reliable discriminatory tests are essential to define and select patients at high risk of progression before irreversible loss of renal tissue, while avoiding drug exposure in others.

引用

页码：249 / 251

页数：3

共 16 条

[1]

Quantitative appraisal IgA nephropathy [J].

Ballardie, Francis W. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (11) :2806-2809

[2]

IgA nephropathy treatment 25 years on: can we halt progression? The evidence base [J].

Ballardie, FW .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1041-1046

[3]

Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142

[4]

The indeterministic character of evolutionary theory: No ''no hidden variables proof'' but no room for determinism either [J].

Brandon, RN ;

Carson, S .

PHILOSOPHY OF SCIENCE, 1996, 63 (03) :315-337

[5]

Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins [J].

Burton, CJ ;

Combe, C ;

Walls, J ;

Harris, KPG .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) :2628-2633

[6]

DETECTION OF ABNORMAL PERIPHERAL-BLOOD MONONUCLEAR CELL CYTOKINE NETWORKS IN HUMAN-IGA NEPHROPATHY [J].

DECAESTECKER, MP ;

BOTTOMLEY, M ;

TELFER, BA ;

HUTCHINSON, IV ;

VOSE, BM ;

BALLARDIE, FW .

KIDNEY INTERNATIONAL, 1993, 44 (06) :1298-1308

[7]

The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease [J].

Eardley, KS ;

Zehnder, D ;

Quinkler, M ;

Lepenies, J ;

Bates, RL ;

Savage, CO ;

Howie, AJ ;

Adu, D ;

Cockwell, P .

KIDNEY INTERNATIONAL, 2006, 69 (07) :1189-1197

[8]

Expression of epidermal growth factor and its receptor in normal and diseased human kidney: An immunohistochemical and in situ hybridization study [J].

Gesualdo, L ;

DiPaolo, S ;

Calabro, A ;

Milani, S ;

Maiorano, E ;

Ranieri, E ;

Pannarale, G ;

Schena, FP .

KIDNEY INTERNATIONAL, 1996, 49 (03) :656-665

[9]

Grandaliano G, 1996, J AM SOC NEPHROL, V7, P906

[10]

LEMLEY KV, 2007, NEPHROL DIAL TR 0922

← 1 2 →